AONs have been used in CEP290-LCA fibroblasts to provide proof-of-principle that aberrant CEP290 splicing can be corrected, and the ciliation defect of affected cells can be restored (Collin et al., 2012, Gerard et al., 2012). The gene discussed is CEP290; the disease is Leber congenital amaurosis.